Acquisitions Business Acquisitions (Details) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		9 Months Ended		3 Months Ended		3 Months Ended					9 Months Ended		12 Months Ended		3 Months Ended				3 Months Ended		3 Months Ended			9 Months Ended
	Mar. 31, 2012	Mar. 26, 2011	Mar. 31, 2012	Mar. 26, 2011	Mar. 31, 2012 CanAm Care LLC [Member]	Jan. 06, 2012 CanAm Care LLC [Member]	Dec. 31, 2011 Paddock Laboratories Inc [Member]	Sep. 24, 2011 Paddock Laboratories Inc [Member]	Jun. 25, 2011 Paddock Laboratories Inc [Member]	Mar. 26, 2011 Paddock Laboratories Inc [Member]	Dec. 25, 2010 Paddock Laboratories Inc [Member]	Mar. 31, 2012 Paddock Laboratories Inc [Member] years	Mar. 26, 2011 Paddock Laboratories Inc [Member]	Jun. 25, 2011 Paddock Laboratories Inc [Member]	Jul. 26, 2011 Paddock Laboratories Inc [Member]	Mar. 31, 2012 Customer Relationships [Member] CanAm Care LLC [Member] years	Mar. 31, 2012 Developed Product Technology [Member] CanAm Care LLC [Member] years	Mar. 31, 2012 Developed Product Technology [Member] Paddock Laboratories Inc [Member]	Mar. 31, 2012 In Process Research And Development [Member] Paddock Laboratories Inc [Member]	Mar. 31, 2012 Noncompete Agreements [Member] CanAm Care LLC [Member] years	Mar. 31, 2012 Trade Names And Trademarks [Member] CanAm Care LLC [Member]	Mar. 31, 2012 Rx Pharmaceuticals [Member]	Sep. 24, 2011 Rx Pharmaceuticals [Member]	Mar. 26, 2011 Rx Pharmaceuticals [Member]	Mar. 31, 2012 Rx Pharmaceuticals [Member]	Mar. 26, 2011 Rx Pharmaceuticals [Member]	Mar. 31, 2012 Rx Pharmaceuticals [Member] Paddock Laboratories Inc [Member]	Mar. 31, 2012 Initial Valuation [Member] Paddock Laboratories Inc [Member]	Mar. 31, 2012 Measurement Period Adjustments [Member] Paddock Laboratories Inc [Member]
Business Acquisition [Line Items]
Acquisition purchase price						$ 39,014
Cash paid						36,114									212,052
Fair value of contingent consideration						2,900
Revenues					7,800
Operating loss	146,070	122,913	408,290	366,919	(200)																	69,594		31,141	168,892	82,091
Preliminary allocation of acquisition purchase price
Accounts receivable					3,568							55,467																55,467	0
Inventory					6,391							57,540																57,540	0
Property and equipment					91							33,200																33,200	0
Other assets					126							1,743																1,743	0
Deferred income tax assets					625							20,519																20,863	(344)
Goodwill					15,040							148,865																150,035	(1,170)
Intangible assets					15,830							272,000				12,000	1,600			1,540	690							272,000	0
Total assets acquired					41,671							589,334																590,848	(1,514)
Accounts payable					2,237							10,685																10,685	0
Other current liabilities					420							2,386																2,386	0
Accrued customer programs												26,249																26,926	(677)
Accrued expenses												3,799																3,799	0
Total liabilities assumed					2,657							43,119																43,796	(677)
Net assets acquired					39,014							546,215																547,052	(837)
Acquired intangible assets, average estimated useful lives (in years)																15,000	20,000			5,000
Amount of Acquisition Funded by Term Loan															250,000
Amount of acquisition funded by accounts receivable securitization program															85,000
Acquisition costs			9,400						550	695	1,315	5,600		2,560
Business Combination, Integration Related Costs							600																3,200				3,800
Revenue of acquiree contributed												169,400
Operating loss of acquiree												34,400
Inventory step-up charges								27,179
Business Acquisition, Purchase Price Allocation, Amortizable Intangible Assets												272,000						237,000
In-process research and development (IPR&D)																			35,000
Acquired intangible assets, average estimated useful lives (in years)												10
Fixed assets fair value adjustment												7,400
Proceeds from sale of intangible assets and pipeline R&D projects			10,500	0								10,500
Proceeds from sale of intangible assets												7,000
Intangible Asset Fair Value Adjustment												7,000
Gain on sale of pipeline development projects			3,500	0								3,500
Net sales												2,376,546	2,247,105
Income from continuing operations												309,348	241,150
Basic earnings from continuing operations per share												$ 3.32	$ 2.62
Diluted earnings from continuing operations per share												$ 3.29	$ 2.58
Inventory adjustments												27,179
Amortization of acquired intangible assets												17,800
Interest expense												6,800
Debt associated with acquisition												$ 335,000